Ignite Creation Date:
2024-05-06 @ 12:33 AM
Last Modification Date:
2024-10-26 @ 10:51 AM
Study NCT ID:
NCT01601639
Status:
COMPLETED
Last Update Posted:
2017-01-25
First Post:
2012-05-14
Brief Title:
Endoscopic Band Ligation Versus Argon Plasma Coagulation for the Treatment of Gastric Antral Vascular Ectasia a Randomized Clinical Trial
Sponsor:
University of Alberta
Organization:
University of Alberta
Study Overview
Official Title:
Endoscopic Band Ligation vs Argon Plasma Coagulation for the Treatment of Gastric Antral Vascular Ectasia a Randomized Clinical Trial
Status:
COMPLETED
Status Verified Date:
2017-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators goal is to compare the standard argon plasma coagulation APC treatment with endoscopic band ligation EBL in patients with Gastric Antral Vascular Ectasia
Detailed Description:
Gastric antral vascular ectasia GAVE is a vascular structural malformation in the stomach that can lead to active or chronic intermittent gastrointestinal bleeding or chronic iron-deficiency anemia
The current standard endoscopic treatment is with APC There have been multiple reports and case series in the literature about successful treatment with EBL for GAVE even in cases where APC was unsuccessful for treatment of GAVE Our goal is to compare the standard APC treatment with EBL in patients with Gastric Antral Vascular Ectasia
The current standard endoscopic treatment is with APC There have been multiple reports and case series in the literature about successful treatment with EBL for GAVE even in cases where APC was unsuccessful for treatment of GAVE Our goal is to compare the standard APC treatment with EBL in patients with Gastric Antral Vascular Ectasia
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None